2010
DOI: 10.1016/j.tripleo.2009.08.039
|View full text |Cite
|
Sign up to set email alerts
|

X-Ray diffraction analysis of White ProRoot MTA and Diadent BioAggregate

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

9
94
2
9

Year Published

2010
2010
2017
2017

Publication Types

Select...
5
2
1

Relationship

1
7

Authors

Journals

citations
Cited by 78 publications
(114 citation statements)
references
References 17 publications
9
94
2
9
Order By: Relevance
“…This could be attributed to the persistent infection and chronic inflammation. Both MTA and BioAggregate subgroups showed a significant lower mean inflammatory cell count than positive subgroup due to sealing ability, biocompatibility and alkaline pH on setting (Schwartz et al, 1999;Park et al, 2010). In addition, the closure of the access cavity prevents further infection at the furaction perforation.…”
Section: Discussionmentioning
confidence: 98%
See 2 more Smart Citations
“…This could be attributed to the persistent infection and chronic inflammation. Both MTA and BioAggregate subgroups showed a significant lower mean inflammatory cell count than positive subgroup due to sealing ability, biocompatibility and alkaline pH on setting (Schwartz et al, 1999;Park et al, 2010). In addition, the closure of the access cavity prevents further infection at the furaction perforation.…”
Section: Discussionmentioning
confidence: 98%
“…Sci., 9 (4): 148-156, 2015 recently, new products similar to MTA have been introduced into the market including MTA Angelus and MTA Bio and BioAggregate (Zhang et al, 2009). BioAggregate appears to be a modified version of MTA; it is a new retrograde filling and root canal perforation repair material (Park et al, 2010).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[9][10][11][12] Park et al examined the chemical composition of BioAggregate and reported that it contained a significant amount of tantalum oxide instead of bismuth oxide. 9 The major compo- 12 Bioaggregate appears to be a modified or synthetic version of original MTA. Since the clinical indications of Bioaggregate are the same as those of MTA, it might be helpful to compare this new material with MTA, which has already been studied and proven to be effective and biocompatible over the past few years.…”
Section: Introductionmentioning
confidence: 99%
“…The major difference between MTA is that BioAggregate is aluminium-free and contains a significant amount of tantalum oxide instead of bismuth oxide and calcium phosphate. [30,31] This aluminium-free property might increase its biocompatibility.…”
Section: Microscopy Resultsmentioning
confidence: 99%